Beobachtungsplan, NIS 219: ACT-iON, MA27950 A Global Comparative Observational Study in Rheumatoid Arthritis (RA) Patients who are Treated with a TNF Inhibitor or Tocilizumab as the First Biologic Therapy

Datei

• Artikel "Beobachtungsplan, NIS 219: ACT-iON, MA27950 A Global Comparative Observational Study in Rheumatoid Arthritis (RA) Patients who are Treated with a TNF Inhibitor or Tocilizumab as the First Biologic Therapy"Herunterladen(PDF, 1MB, Datei ist nicht barrierefrei)